Achondroplasia is a genetic skeletal condition caused by FGFR3 pathogenic variants. Infigratinib, an oral FGFR1–3 tyrosine kinase inhibitor, down-regulates key pathways in the pathogenesis of ...
Elaine’s stories explore the boom in new obesity treatments, new drug payment models, the ways companies are affected by FDA changes, and the emerging psychedelics drug sector. She co-writes The ...
Gurugram: As part of an ongoing drive, the enforcement wing of the Department of Town and Country Planning (DTCP) on Friday sealed seven residential properties on the Nathupur Road in DLF Phase-3 for ...
After being left unprotected in Phase 1, Julia Gosling rejected an FPO in Phase 2 to remain a part of the Seattle Torrent's core. Troy Parla / Getty Images The third phase of the PWHL’s multi-step ...
COLORADO (KOAA) — Colorado Governor Jared Polis has activated Phase 3 of the state's Drought Response Plan and issued a statewide Drought Emergency declaration. The declaration and plan activation are ...
Retatrutide met primary and key secondary endpoints in a 2339-participant, randomized, double-blind, placebo-controlled phase 3 trial, demonstrating clinically meaningful weight reduction across 4, 9, ...
SAO PAULO, May 19 (Reuters) - Brazil's Finance Ministry on Tuesday released a preliminary proposal for phased sectoral coverage of the country's regulated carbon market, outlining which industries ...
When you order a new broadcast transmitter, one of the first questions will be about power. Is it single-phase or three-phase alternating current? If single-phase, it is 208 or 240 volts? If it is ...
The U.S. Space Force is requesting industry input to identify launch providers that could support up to 25 high-priority National Security Space Launch Phase 3 missions scheduled for fiscal years 2027 ...
Compass Pathways has announced that its investigational psilocybin treatment has successfully met its primary endpoint in a second Phase 3 clinical trial moving it one step closer to FDA submission.
Altimmune closed a $75M direct offering to fund Phase 3 pemvidutide trials for MASH, leveraging recent positive Phase 2b data and FDA Breakthrough Therapy status. Pemvidutide’s dual GLP-1/glucagon ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results